Fresenius Kabi AG
Profile managed by Bizz IdFresenius Kabi Contract Manufacturing
Description
Products
72 productsBrand: Idacio (adalimumab-aacf). Citrate-free biosimilar of Humira. RA, polyarticular JIA, PsA, AS, Crohn's disease, UC, plaque psoriasis, hidradenitis suppurativa and uveitis.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Biosimilar of Eylea. Late-stage development.
Under development
Finished product (FDF)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Local anaesthetic
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
API no oncológico listado como disponible previa evaluación en el portafolio de Oncology & Specialty (planta de Kalyani, India)
Under development
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Brand: Conexxence (denosumab-bnht). Interchangeable biosimilar of Prolia. Postmenopausal, male and glucocorticoid-induced osteoporosis; bone loss on ADT or aromatase inhibitors.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Brand: Bomyntra (denosumab-bnht). Interchangeable biosimilar of Xgeva. Prevention of skeletal-related events in multiple myeloma and bone metastases, giant cell tumour of bone and hypercalcaemia of malignancy. Vial and prefilled syringe.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Commercially available generic peptide API supported by a US DMF. Produced at Villadose (Italy) using chemo-enzymatic (CEPS) and solid-phase (SPPS) peptide synthesis
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Commercially available generic peptide API supported by a US DMF. Produced at Villadose (Italy) using chemo-enzymatic (CEPS) and solid-phase (SPPS) peptide synthesis
API (active ingredient)
Verified on 2026-10-21
Lactulose API in two grades: liquid (~67% w/v) produced by a proprietary solvent-free process in EP and USP quality; and crystalline (>99% w/w) manufactured under cGMP
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Finished dosage forms of lactulose in bottles and single-dose stick packs, supplied under own brand and through private-label partnerships
Tech pack available
Finished product (FDF)
Verified on 2026-10-21
Local anaesthetic
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Commercially available generic peptide API supported by a US DMF. Produced at Villadose (Italy) using chemo-enzymatic (CEPS) and solid-phase (SPPS) peptide synthesis
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Commercially available generic peptide API supported by a US DMF. Produced at Villadose (Italy) using chemo-enzymatic (CEPS) and solid-phase (SPPS) peptide synthesis
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Sterile and lyophilized manufacturing of crystallized penicillins
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Brand: Stimufend (pegfilgrastim-fpgk). Biosimilar of Neulasta. Reduces febrile neutropenia in non-myeloid malignancies on myelosuppressive chemotherapy; haematopoietic subsyndrome of acute radiation syndrome. 6 mg/0.6 mL prefilled syringe. Stimufend OBI (on-body injector, ref. Neulasta Onpro) presentation in late-stage development.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Piperacillin: see suppliers → · Tazobactam Sodium EDTA: see suppliers →
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Biosimilar of Rituxan. Filed for FDA approval.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Local anaesthetic
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Commercially available generic peptide API supported by a US DMF. Produced at Villadose (Italy) using chemo-enzymatic (CEPS) and solid-phase (SPPS) peptide synthesis
API (active ingredient)
Verified on 2026-10-21
Tech pack available
API (active ingredient)
Verified on 2026-10-21
Brand: Tyenne (tocilizumab-aazg). Biosimilar of Actemra, IV and SC (prefilled autoinjector). RA, giant cell arteritis, pJIA, sJIA, CAR-T induced CRS and hospitalised COVID-19.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Brand: Otulfi (ustekinumab-aauz). Interchangeable biosimilar of Stelara. Plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Certifications
Contact company
Other locations
Via San Leonardo, 23, 45010 Villadose (RO) (Italy)
Kalyani (India)